NOK 2.49
(3.11%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | - NOK | 0.0% |
2022 | - NOK | 0.0% |
2021 | - NOK | 0.0% |
2020 | - NOK | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | - NOK | 0.0% |
2024 Q2 | - NOK | 0.0% |
2023 Q1 | - NOK | 0.0% |
2023 FY | - NOK | 0.0% |
2023 Q2 | - NOK | 0.0% |
2022 FY | - NOK | 0.0% |
2021 FY | - NOK | 0.0% |
2020 FY | - NOK | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Arctic Bioscience AS | 9.77 Million NOK | 100.0% |
Aqua Bio Technology ASA | 607.92 Thousand NOK | 100.0% |
ArcticZymes Technologies ASA | 113.01 Million NOK | 100.0% |
BerGenBio ASA | 354 Thousand NOK | 100.0% |
Hofseth BioCare ASA | 29.87 Million NOK | 100.0% |
PCI Biotech Holding ASA | 2.99 Million NOK | 100.0% |
Ultimovacs ASA | -2.76 Million NOK | 100.0% |